|
|
||||||||
Ann Thorac Surg 1985;39:53-60
© 1985 The Society of Thoracic Surgeons
From the Divisions of Cardiovascular Surgery, Biochemistry, Anesthesia, and Nuclear Cardiology, Toronto General Hospital and University of Toronto, Toronto, Ont, Canada
* Address reprint requests to Dr. Weisel, Cardiovascular Surgery, Toronto General Hospital, 200 Elizabeth St, Eaton N 13-224, Toronto, Ont, Canada M5G 1L7
Nitroglycerin improves perfusion to ischemic myocardial regions and therefore has theoretical advantages over sodium nitroprusside to treat hypertension (mean arterial pressure [MAP] greater than 95 mm Hg) following coronary bypass operation. Thirty-three hypertensive patients were randomized to an initial infusion of either nitroglycerin or nitroprusside in a crossover trial designed to reduce MAP to 85 mm Hg. Thermodilution cardiac output measurements permitted calculation of left ventricular stroke work index (LVSWI), and nuclear ventriculograms permitted estimation of left ventricular ejection fraction, left ventricular end-diastolic volume index (LVEDVI), and left ventricular end-systolic volume index (LVESVI). Coronary sinus blood flow was measured by the continuous thermodilution technique, and arterial and coronary sinus lactate measurements permitted calculation of myocardial lactate flux (MV·L).
Both nitroglycerin and nitroprusside reduced MAP (– 25 ± 12 mm Hg and – 20 ± 10 mm Hg, respectively; not significant [NS]). Nitroglycerin reduced LVSWI more than did nitroprusside (–15 ± 13 gm-m/m2 and –7 ± 9 gm-m/m2, respectively; p < 0.01). Both agents increased left ventricular ejection fraction (nitroglycerin, +8 ± 8%, and nitroprusside, + 10 ± 7%; NS), and decreased LVEDVI (-20 ± 22 ml/m2 and –11 ± 17 ml/m2, respectively; NS) and LVESVI (–13 ± 14 ml/m2 and –10 ± 12 ml/m2, respectively; NS). Coronary sinus blood flow decreased with both drugs (NS), but MV·L increased with nitroglycerin (+ 0.02 ± 0.14 mmol/min) and decreased with nitroprusside (-0.02 ± 0.02 mmol/min) (p < 0.05). Both medications controlled hypertension following coronary bypass grafting, but only nitroglycerin improved myocardial metabolism. While either nitroglycerin or nitroprusside may be used after routine operation, nitroglycerin is preferred for patients with suspected perioperative ischemia.
This article has been cited by other articles:
![]() |
K. S. Lewis Pharmacological Review of Postoperative Hypertension Journal of Pharmacy Practice, April 1, 2002; 15(2): 135 - 146. [Abstract] [PDF] |
||||
![]() |
J. G. van der Stroom Influence of Vasodilator Drugs on Perioperative Blood Pressure Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 204 - 221. [Abstract] [PDF] |
||||
![]() |
M. Nordlander, M. Pfaffendorf, and H. B. van Wezel Calcium Antagonists for Perioperative Blood Pressure Control Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 231 - 242. [Abstract] [PDF] |
||||
![]() |
R. M. Bojar, H. Rastegar, D. D. Payne, S. H. Harkness, M. R. England, J. J. Stetz, B. Weiner, and R. J. Cleveland Methemoglobinemia from Intravenous Nitroglycerin: A Word of Caution Ann. Thorac. Surg., March 1, 1987; 43(3): 332 - 334. [Abstract] [PDF] |
||||
![]() |
S. E. Fremes, R. D. Weisel, D. A. G. Mickle, S. J. Teasdale, A. P. Aylmer, G. T. Christakis, M. M. Madonik, J. Ivanov, S. Houle, P. R. McLaughlin, et al. A Comparison of Nitroglycerin and Nitroprusside: II. The Effects of Volume Loading Ann. Thorac. Surg., January 1, 1985; 39(1): 61 - 67. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |